Sort
15,440 grants matching “organoids”
Discovery and therapeutic targeting of biological determinants of lung cancer health disparities
$373,775Sharon R. Pine · University Of Colorado Denver · R01 · FY2022 · CA
Development of Human Intestinal Simulacra
$373,736Nancy L Allbritton · Univ Of North Carolina Chapel Hill · R01 · FY2019 · DK
RP-1: Defining Predictors of Sensitivity to Cisplatin-Based Chemotherapy in Urothelial Cancer
$373,548David B. Solit · Sloan-Kettering Inst Can Research · P50 · FY2020 · CA
Exploring p53-mediated ferroptosis to treat IDH1-mutant glioma
$373,450L. Eric Huang · University Of Utah · R01 · FY2024 · NS
The kynurenine-AHR pathway in biomass production
$373,434Maralice Conacci-Sorrell · Ut Southwestern Medical Center · R01 · FY2020 · CA
Injectable Hybrid SMART spheroids to enhance stem cell therapy for CNS injuries
$373,413Kibum Lee · Rutgers, The State Univ Of N.J. · R01 · FY2024 · NS
Mechanisms underlying non-REM sleep and neural oscillation abnormalities in Dup15q and Rett Syndrome: Effects on Intellectual Disability
$373,350Bennett G Novitch · University Of California Los Angeles · P50 · FY2020 · HD
Mechanisms underlying non-REM sleep and neural oscillation abnormalities in Dup15q and Rett Syndrome: Effects on Intellectual Disability
$373,350Bennett G Novitch · University Of California Los Angeles · P50 · FY2021 · HD
Mechanisms underlying non-REM sleep and neural oscillation abnormalities in Dup15q and Rett Syndrome: Effects on Intellectual Disability
$373,350Bennett G Novitch · University Of California Los Angeles · P50 · FY2023 · HD
Mechanisms underlying non-REM sleep and neural oscillation abnormalities in Dup15q and Rett Syndrome: Effects on Intellectual Disability
$373,350Bennett G Novitch · University Of California Los Angeles · P50 · FY2022 · HD
Bioreactor-based Manufacturing of Glioblastoma Organoids
$373,293Yonghyun Kim · University Of Alabama Tuscaloosa · · FY2020 · ENG
Regulation of mammary branching morphogenesis by Slit/Robo1 signaling
$373,220Lindsay E Hinck · University Of California Santa Cruz · R01 · FY2012 · GM
Cellular and molecular characterization of the digestive tract sub-epithelium
$373,122Ramesh A Shivdasani · Dana-Farber Cancer Inst · R01 · FY2019 · DK
Neurobiology of Autism With Macrocephaly
$373,118Flora M Vaccarino · Yale University · R01 · FY2021 · MH
A streamlined, high-throughput platform for validation of cancer antigen presentation and isolation of cancer antigen reactive T cells
$373,068Ning Jenny Jiang · University Of Pennsylvania · R33 · FY2022 · CA
Ornithine Aminotransferase Inactivation, a New Approach for Treatment of Cancers
$373,062Richard B Silverman · Northwestern University · R01 · FY2025 · CA
Mitigation of Radiation Damage to the Immunohematopoietic System
$373,052William H. McBride · University Of California Los Angeles · U19 · FY2014 · AI
Targeting SUMO1 degradation for advanced colon cancer therapy
$373,036Anita Bellail · Indiana University Indianapolis · R01 · FY2025 · CA
Mechanisms of tumor initiation upon disruption of the Rb/E2f interaction
$372,989Patrick Viatour · Lankenau Institute For Medical Research · R01 · FY2023 · CA
Core 1: Pathology Core
$372,800Keith L Ligon · Brigham And Women'S Hospital · P50 · FY2024 · CA
Multiplex FRET Imaging of Kinase-Epigenome Interregulations in Live Cancer Cells
$372,796Yingxiao Wang · University Of California, San Diego · R33 · FY2019 · CA
Targeting HuR to improve a synthetic lethal therapy for pancreatic cancer
$372,748Jonathan Brody · Thomas Jefferson University · R01 · FY2018 · CA
CANCAN - SALK
$372,748Janelle S Ayres · Salk Institute For Biological Studies · OT2 · FY2024 · CA
New Strategies for Treatment of NRAS Mutant Melanoma after Progression on Immune Checkpoint Inhibitors
$372,669Ann Richmond · Vanderbilt University · R01 · FY2022 · CA
Project 2: Bromodomains as Epigenetic Modulators of Endocrine Responsiveness in ER+ Breast Cancer
$372,616Seth E Frietze · University Of Vermont & St Agric College · P01 · FY2022 · CA